Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Lowest PSA Level Achieved Before CRPC Predicts Abiraterone Response But Not Enzalutamide Response in Metastatic CRPC.

The Prostate·2026
Same author

Kidney Biopsy of a Patient With Double Positive Antiglomerular Basement Membrane and Myeloperoxidase-antineutrophil Cytoplasmic Antibodies.

Kidney medicine·2026
Same author

A Nomogram Predicts the Need for Internal Iliac Vein Dissection During Renal Transplantation: A Multicenter Collaborative Study.

Transplantation proceedings·2026
Same author

Distinct glomerular and tubulointerstitial injury pathways in infective endocarditis-associated glomerulonephritis: a case series.

Clinical and experimental nephrology·2026
Same author

Donor Acute Kidney Injury and Outcomes After Deceased Donor Kidney Transplantation: A 50-Case Single-Center Study From Japan.

Clinical transplantation·2026
Same author

Efficacy and Safety of Enzalutamide and Abiraterone in CRPC Patients With a History of Other Cancers: A Sub-Analysis of the ENABLE Study for PCa.

International journal of urology : official journal of the Japanese Urological Association·2026

Related Experiment Video

Updated: Jun 20, 2026

Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

Appropriate Risk Classification and Low-Dose Rituximab May Help Prevent Acute Rejection in ABO-Compatible Living

Miruzato Fukuda1, Takayoshi Yokoyama1, Katsuyuki Miki2

  • 1Center of Renal Surgery, Toranomon Hospital, Tokyo, Japan.

Transplantation Proceedings
|June 18, 2026
PubMed
Summary

Low-dose rituximab in ABO-compatible kidney transplants may prevent rejection in high-risk patients without increasing infections. This approach, guided by a risk-classification framework, shows promise for improving transplant outcomes.

Related Experiment Videos

Last Updated: Jun 20, 2026

Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

Area of Science:

  • Nephrology
  • Immunology
  • Transplantation Medicine

Background:

  • Rituximab desensitization is effective in ABO-incompatible kidney transplants.
  • Acute rejection can still occur in ABO-compatible transplants, indicating undetected antibodies.
  • Previous ABO-compatible transplant studies used conventional rituximab dosing without risk stratification.

Purpose of the Study:

  • To assess the efficacy of low-dose rituximab in ABO-compatible kidney transplant recipients.
  • To propose a preoperative risk-classification framework for rituximab use in ABO-compatible transplants.

Main Methods:

  • Retrospective review of 158 ABO-compatible living-donor kidney transplants (Jan 2015 - Jul 2024).
  • Recipients stratified into rituximab (single 200 mg dose pre-transplant) and rituximab-free groups.
  • Primary endpoints: 1-year acute rejection and infection rates.

Main Results:

  • The rituximab group had higher immunologic risk (more sensitized, donor-specific antibody-positive).
  • 1-year acute rejection was lower in the rituximab group (0% vs 10.8%), with a trend toward improved rejection-free survival.
  • 1-year infection rates were similar between groups (21.4% vs 23.1%).
  • In DSA-positive patients, rituximab prevented rejection.

Conclusions:

  • Risk-stratified preoperative low-dose rituximab may prevent rejection in ABO-compatible kidney transplant recipients without increasing infections.
  • A proposed risk-stratification framework could guide patient selection.
  • Further validation in larger prospective studies is needed.